Fujian South Pharmaceutical Co., Ltd.

Fuiian South Pharmaceutical Co, Ltd. (Stock Code: 831207), was founded in September 2001. lt has a registered capital of 180 million RMB and the total assets nearly 100 billion RMB with over 400 staff. FSP is a GMP pharmaceutical manufacturer integrating planting, R&D, production and sales. For more than 20 years, we have been committed to the R&D, productions of APl, pharmaceutical intermediate and technology development, which including anti-tumor APl represented by paclitaxel, anti-virus series, anti-epileptic series and cardiovascular series. Our markets are covering in EU, UK, USA, India, Russia, Brazil Argentina, Mexico, Turkey, South Korea, Hong Kong etc. The plant Passed GMP inspection by China NMPA, EU-EDOM, US-FDA and Mexico COFEPRIS.